Olympus inks endoscope image sharing deal with InterSystems
Olympus (TYO:7733) said yesterday it inked a deal with InterSystems to enhance Olympus’ Knowledge Exchange System with InterSystems HealthShare, which allows for the sharing of images taken during endoscopy procedures. Olympus said its KE system is a software platform for centralized reprocessing record and image management that connects to its Olympus devices. The company added the system eliminates the need to transfer images to external devices to share with patients and other providers, and that with the addition of HealthShare it will now be able share endoscopic images and to directly connect to electronic...
Source: Mass Device - April 20, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Endoscopic / Arthroscopic Imaging Software / IT intersystems Olympus Source Type: news
FDA warns against endoscope connectors
The FDA yesterday warned healthcare providers against using endoscope connectors in more than one patient without reprocessing, saying it hasn’t seen any acceptable tests demonstrating their safety. The federal safety watchdog said the connectors, which are used in more than one patient for gastrointestinal endoscopies over the course of 24 hours, connect the endoscope to a water supply. The agency recommended that providers use connectors that prevent patient fluid back-flow into the ‘scope, either as a one-time use or reprocessed after every patient. Erbe USA is the only company marketing a 24-hour multi-pati...
Source: Mass Device - April 19, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Endoscopic / Arthroscopic Food & Drug Administration (FDA) Erbe USA Source Type: news
Cleaned endoscopes often contaminated
Many patients may be undergoing endoscopy with contaminated instruments, a pair of new studies suggest. (Source: Reuters: Health)
Source: Reuters: Health - April 18, 2018 Category: Consumer Health News Tags: healthNews Source Type: news
Cantel Medical wins FDA nod for Advantage Plus endoscope reprocessor
Cantel Medical (NYSE:CMD) said today it won FDA 510(k) clearance for its Advantage Plus pass-thru automated endoscope reprocessor, making it the first AER available in the US, the company claims. The newly cleared device is designed for the high-level disinfection of commonly used endoscopes, including duodenoscopes, the Little Falls, N.J.-based company said. “We strive to deliver real life infection prevention solutions to address the complexities our customers face in setting up successful endoscopy departments. We believe the Advantage Plus pass-thru AER’s availability will transform our custo...
Source: Mass Device - April 18, 2018 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Endoscopic / Arthroscopic Food & Drug Administration (FDA) Regulatory/Compliance Cantel Medical Corp. Source Type: news
Boston Sci Continues M & amp;A Hot Streak with nVision Buy
Boston Scientific isn’t slowing down with its M&A activity. This time the Marlborough, MA-based company is acquiring nVision Medical, a private company focused on women's health. The transaction consists of an upfront cash payment of $150 million, and up to an additional $125 million in potential clinical and commercial milestones over four years. nVision’s device collects cells from the fallopian tubes, offering a potential platform for earlier diagnosis of ovarian cancer. “nVision Medical developed the first and only device cleared by the FDA to collect cells from the fallopian tubes,” K...
Source: MDDI - April 16, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news
New recommendations for endoscopic eradication therapy in Barrett's esophagus
(American Society for Gastrointestinal Endoscopy) A new guideline by the ASGE Standards of Practice Committee offers evidence-based recommendations and clinical guidelines addressing key issues related to Endoscopic Eradication Therapy (EET) in the management of Barrett's esophagus (BE)-related lesions. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 6, 2018 Category: International Medicine & Public Health Source Type: news
Applied Medical touts surgical GI wound protector study data
Applied Medical this week released results from a meta-analysis study of wound protectors used during lower gastro intestinal procedures, touting their ability to reduce surgical site infections. Results from the study were published this month in the journal Surgical Endoscopy, the Rancho Santa Margarita, Calif.-based company said. Data from the analysis, which examined 12 randomized controlled trials with 3,029 participants, indicated that use of wound protectors like the company’s Alexis system significantly reduced rates of SSI patients undergoing lower GI surgery. Furthermore, SSI rates were reduced by 63% when ...
Source: Mass Device - March 30, 2018 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Surgical Applied Medical Resources Corp. Source Type: news
OmniGuide ’ s Domain Surgical launches ferromagnetic vessel-sealing shears
OmniGuide said yesterday its subsidiary Domain Surgical launched its FMsealer laparoscopic shears designed for surgical vessel sealing. The Lexington, Mass.-based company touted the newly released FMsealer as the only vessel sealing instrument based on ferromagnetic surgical energy, which it claims provides quick transection with minimal thermal impact on surrounding tissue. The device is cleared for sealing vessles up to 7mm in diameter, including lymphatics in open and laparoscopic procedures, OmniGuide said. “The FMsealer Laparoscopic Shears offers intuitive plug-and-play capabilities with our award-winning F...
Source: Mass Device - March 30, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Surgical Vascular Domain Surgical OmniGuide Source Type: news
CDx & #039;s WATS3D Highly Effective in Real World Setting
CDx Diagnostics said results from a recent multicenter prospective trial show the use of its WATS3D test increases the detection of both Barrett’s esophagus and esophageal dysplasia by more than 80%. The results were published in the latest issue of United European Gastroenterology Journal and featured in the American Society for Gastrointestinal Endoscopy (ASGE’s) Scope Tech Talk Video Series. The trial was conducted at 25 community-based gastrointestinal (GI) centers across the U.S. In the study, 4,203 patients were tested for esophageal disease. The findings show that with the inclusion of WATS3D overal...
Source: MDDI - March 26, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Design News Source Type: news
UPDATE: Moll ’ s Auris wins FDA nod for Monarch robotic endoscopy platform
Updated to include commentary from Auris chief strategy officer Josh DeFonzo. Auris Health, previously known as Auris Surgical Robotics and formed by Intuitive Surgical (NSDQ:ISRG) founder Dr. Frederic Moll, said today it won FDA clearance for its Monarch robotic endoscopy platform. The Redwood City, Calif.-based company said it’s Monarch robotic platform’s initial aim will be on treating lung cancer, with the FDA clearance indicating the device for use in diagnostic and therapeutic bronchoscopic procedures. Auris touted that the system enables more accurate diagnosis and treatment of small and hard-to-rea...
Source: Mass Device - March 23, 2018 Category: Medical Devices Authors: Fink Densford Tags: Endoscopic / Arthroscopic Food & Drug Administration (FDA) Regulatory/Compliance Respiratory Robotics aurishealth Source Type: news
Moll ’ s Auris wins FDA nod for Monarch robotic endoscopy platform
Auris Health, previously known as Auris Surgical Robotics and formed by Intuitive Surgical (NSDQ:ISRG) founder Dr. Frederic Moll, said today it won FDA clearance for its Monarch robotic endoscopy platform. The Redwood City, Calif.-based company said it’s Monarch robotic platform’s initial aim will be on treating lung cancer, with the FDA clearance indicating the device for use in diagnostic and therapeutic bronchoscopic procedures. Auris touted that the system enables more accurate diagnosis and treatment of small and hard-to-reach nodules in the periphery of the lung. “Technology has advanced signif...
Source: Mass Device - March 23, 2018 Category: Medical Devices Authors: Fink Densford Tags: Endoscopic / Arthroscopic Food & Drug Administration (FDA) Regulatory/Compliance Respiratory Robotics aurishealth Source Type: news
Urgent Endoscopy Predicts Lower Death Rate in UGIB (CME/CE)
(MedPage Today) -- But did not impact rebleeding rate in high-risk acute nonvariceal upper GI bleeding (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - March 21, 2018 Category: Gastroenterology Source Type: news
March Madness: Boston Scientific Continues Buying Spree
Boston Scientific is set to acquire NxThera, a urology specialist, for about $406 million. The transaction consists of an upfront cash payment of $306 million, and up to an additional $100 million in potential commercial milestone payments over the next four years. The deal is set to close in the second quarter of 2018. Maple Grove, MN-based NxThera has developed and commercialized the Rezūm system, which is a minimally invasive therapy for the treatment of symptoms arising from benign prostatic hyperplasia (BPH). The system was cleared by FDA in 2015 and has CE mark. Treatment with the Rezūm system is typicall...
Source: MDDI - March 21, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news
Cantel Medical picks up healthcare software dev Aexis Medical for $25m
Cantel Medical (NYSE:CMD) said today it acquired Belgium-based healthcare software developer Aexis Medical in a deal worth $24.8 million. Through the deal, Little Falls, N.J.-based Cantel Medical will pay $21.1 million up front and $3.7 million in an earnout structure slated to pay out at two-years after the deal closes. Aexis Medical develops integrated information technology solutions designed to support management of instrument reprocessing workflows and data reporting in hospital environments, and employs approximately 60 employees including software developers, sales and other functions, Cantel said. “...
Source: Mass Device - March 21, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Mergers & Acquisitions Software / IT Cantel Medical Corp. Source Type: news
Healing the Patient of Tomorrow
Products on well-understood commercialization tracks often take an incremental approach rather than trying to create paradigm-shifting technologies. In this blog, I’ll take a look at medical devices that are on a commercialization track to heal the patient of tomorrow in a way that is substantially better than previous offerings. They are generally broken into three broad categories based on their advantages over existing medical devices: either healing the patient at home, fixing issues with existing devices, or creating non-invasive diagnostic tools. Connected Home Use Devices Connected home-use devices allow a pat...
Source: MDDI - March 19, 2018 Category: Medical Devices Authors: Nigel Syrotuck Tags: Design Source Type: news
Boston Sci Whets M & amp;A Appetite with EMcision Buy
Boston Scientific could be very busy with M&A this year. During the Marlborough, MA-based company’s most recent earnings call, CEO Michael Mahoney hinted at the possibility of potential acquisitions. “We do have a pretty active M&A appetite,” Mahoney said, according to a transcript from Seeking Alpha. "So, I think you'll see us be active with tuck-in acquisitions to strengthen our category leadership strategy." On Monday, Boston Scientific backed up its CEO’s words and revealed it would strengthen its endoscopy offerings with the acquisition of London – based EMcision, f...
Source: MDDI - March 5, 2018 Category: Medical Devices Authors: Omar Ford Tags: Medical Device Business Source Type: news
Boston Scientific picks up EMcision
Boston Scientific (NYSE:BSX) said today that built out its biliary offering with the acquisition of endoscope maker EMcision for an undisclosed amount. London- and Montreal-based EMcision makes the Habib EndoHPB probe, which is designed to coagulate tissue in the gastrointestinal tract in treating pancreaticobiliary cancers. Marlborough, Mass.-based Boston Scientific said the probe has 510(k) clearance from the FDA and CE Mark approval in the European Union. “As we continue to search for ways to treat pancreaticobiliary cancers, we also seek to improve the quality of life for patients living with a cancer diagno...
Source: Mass Device - March 5, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Endoscopic / Arthroscopic Mergers & Acquisitions Oncology Wall Street Beat Boston Scientific emcision Source Type: news
DDW ® 2018 offers reporters access to leading research in digestive health
(Digestive Disease Week) Digestive Disease Week ® (DDW) will host its annual scientific meeting in Washington, DC, from June 2-5, 2018, bringing together physicians, researchers, and academics from across the world. Recognized as a top 50 medical meeting, this is your opportunity to learn cutting-edge medical advances and report on the latest research in gastroenterology, hepatology, endoscopy and gastrointestinal surgery. This year's press program will offer reporters multiple opportunities to interact with leading researchers from the field. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 16, 2018 Category: Cancer & Oncology Source Type: news
17 black innovators who made medtech better
From cardiology to endoscopy to blood transfusion, African Americans have played an important role as innovators in the history of medicine and medtech. To help mark African American History Month, here’s a look at some of their greatest achievements. Here are 17 black innovators who have made discoveries and invented devices to make medtech better. Next>> The post 17 black innovators who made medtech better appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - February 9, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: Blood Management Cardiac Assist Devices Cardiac Implants Cardiovascular Diagnostics Endoscopic / Arthroscopic Hospital Care Laboratory Instruments/Laboratory Supplies Oncology Pharmaceuticals Research & Development American Red Cross Source Type: news
ANSI/AAMI PB70: Closing the Gap
Discussion during the recent AAMI meeting included the use of correct wording for these products. For example, there was general consensus to include head and boot covers, which are meant to provide liquid barrier protection, and to exclude head caps meant to contain hair and foot covers meant to keep the environment free of contamination. After the October 16 AAMI meeting, the task groups will be working on better clarifying the purpose, definitions, barrier level requirements, and critical areas throughout the entire document. Many agreed diagrams for each product type should be included in the informative section simila...
Source: MDDI - January 5, 2018 Category: Medical Devices Authors: Sarah Smit Tags: Regulatory and Compliance Source Type: news
The ‘ smart pill ’ market could be worth $3B by 2025 – meet the key players
The “smart pill” market is expected to nearly quadruple in value to $3 billion by 2025, according to Grand View Research. Driving this growth is an increasing demand for minimally-invasive procedures, as well as better patient monitoring capabilities. There are a number of players in the pharmaceutical and medtech arenas looking to stake a claim to the smart pill market. The companies are segmented into two groups – those developing capsules used for endoscopy and those creating connected, swallowable drug-tracking systems. Get the full story at our sister site, Drug Delivery Business News. The post The &...
Source: Mass Device - January 4, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Imaging Pharmaceuticals Research & Development Wall Street Beat CapsoVision etectrx Medtronic Olympus Proteus Digital Health Source Type: news
Study: Patient self-audits through mobile app match traditional evaluations
Adherence reports self-generated by bowel surgery patients through an engagement and care management app strongly agreed with those recorded more traditionally by clinical auditors, according to a study recently published in Surgical Endoscopy. (Source: mobihealthnews)
Source: mobihealthnews - December 21, 2017 Category: Information Technology Source Type: news
PENTAX Medical Appoints Veteran Executive As The Americas Region President And CEO
MONTVALE, N.J., Dec. 21, 2017 -- (Healthcare Sales & Marketing Network) -- PENTAX Medical, a healthcare industry leader in endoscopy solutions, announced that David Woods, the current Global Chief Marketing Officer of PENTAX Medical, has been appointed Pr... Devices, Gastroenterology, Personnel PENTAX Medical, endoscope, endoscopy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 21, 2017 Category: Pharmaceuticals Source Type: news
Two surgical approaches equal in treating infection-caused hydrocephalus
(Penn State) Implanting a shunt or endoscopically reducing intracranial pressure and reducing fluid production are equally effective in treating infants with hydrocephalus caused by brain infections, according to an international team of researchers, but endoscopy may have fewer down-the-line complications. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 20, 2017 Category: International Medicine & Public Health Source Type: news
Mauritius:Health Minister Inaugurates Gastrointestinal Endoscopy Unit At Jeetoo Hospital
[Government of Mauritius] Government is determined to provide quality services to all citizens by placing health care at the core of its agenda with the priority of making the latest medical technology accessible to all. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 19, 2017 Category: African Health Source Type: news
Mauna Kea wins expanded FDA 510(k) for Cellvizio
Mauna Kea (ENT:MKEA) said today it won expanded FDA 510(k) clearance for its Cellvizio confocal laser endomicroscopy platform and its Confocal Miniprobe devices. The Cellvizio device is designed for use in a variety of surgical procedures, providing real time visualization at the microscopic level. The system allows the operating physician to visualize the internal microstructure of tissue in real time during ureteroscopic and cytoscopic procedures, Mauna Kea said. With the expanded clearance, the device is now indicated for identification of cells and vessels and their organizations and architecture, the Paris-b...
Source: Mass Device - December 18, 2017 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Imaging Regulatory/Compliance Mauna Kea Technologies Source Type: news
Medtronic Scoops Up an Irish Endoscopy Diagnostics Player
Medtronic has added two endoscopic devices to its portfolio through an acquisition that could be worth up to $45 million, according to various media reports. The new acquisition, Galway, Ireland-based Crospon, provides Medtronic with a functional luminal imaging probe called the Endoflip. The device consists of a balloon catheter that is inserted into the area being measured and injected with a conductive solution to enable electrodes in the balloon to record voltage. The Endoflip builds up a picture of the geometry of the esophagus, pylorus, and anal sphincters using high-resolution impedance planimetry, according to Cros...
Source: MDDI - December 11, 2017 Category: Medical Devices Authors: Amanda Pedersen Tags: Medical Device Business Imaging Source Type: news
Report: Medtronic acquires gastro diag dev Crospon in deal worth $45m
Medtronic (NYSE:MDT) has reportedly acquired gastrointestinal disorder diagnostic company Crospon in a deal that could be worth as much as $45 million (EU €38 million), according to a Times UK report. The Galway, Ireland-based developer was founded in 2006 by current chief exec John O’Dea, and is looking to develop tools to more effectively examine and possibly treat gastrointestinal disorders, according to the report. The company produces endoscopic diagnostics, including its recently FDA-cleared Endoflip system, which includes the company’s Flip topography module designed to allow for the assessment...
Source: Mass Device - December 11, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Diagnostics Mergers & Acquisitions Crospon Medtronic Source Type: news
Case series: treating cannabinoid hyperemesis syndrome with capsaicin cream
3 out of 5 stars Resolution of cannabis hyperemesis syndrome with topical capsaicin in the emergency department: a case series. Dezieck L et al. Clin Toxicol 2017 Sep;55:908-913. Abstract Cannabis hyperemesis syndrome (CHS) is a form of cyclic vomiting characterized by: chronic marijuana use recurrent vomiting, and lack of alternate explanation for symptoms A striking feature is that although CHS-induced nausea and vomiting are frequently resistant to standard antiemetics such as ondansetron, patients often report that very hot showers or baths relieve their symptoms. Several years ago, Jeff Lapoint ...
Source: The Poison Review - December 5, 2017 Category: Toxicology Authors: Leon Gussow Tags: Medical cannabinoid hyperemesis syndrome capsaicin treatment TRPV1 receptor Source Type: news
Quality Standards in Upper Gastrointestinal Endoscopy Quality Standards in Upper Gastrointestinal Endoscopy
This position statement presents the minimum expected standards in diagnostic upper gastrointestinal endoscopy, with a focus on technical competence and procedural safety.Gut (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 5, 2017 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
Prepared for the unexpected: How Henri beat C. diff
Henri and his sister, Lucienne From the time he was born, Henri has been very reactive — to everything. As a baby, he was allergic to milk and soy, which led to weeping eczema all over his body. His allergies meant frequent ear infections and sinus infections. As a toddler, he was anemic and underweight. He had two urinary tract infections (UTIs) with fevers. At age 3, he had a circumcision because of the repeated UTIs. At age 4, a sinus infection spread to his eye orbit. Every sunscreen on the market gave him (and still gives him) a rash. At age 5, a bug bite on his ear led to a cartilage infection that required ant...
Source: Thrive, Children's Hospital Boston - November 29, 2017 Category: Pediatrics Authors: Marie Vedder Tags: Diseases & Conditions Our Patients’ Stories C-diff fecal transplant gastroenterology Lori Zimmerman Sonia Ballal Source Type: news
$1.3M project seeks to move endoscopy rooms to new ambulatory surgery center
Kernersville Endoscopy Center has filed a request with the state to move two gastrointestinal endoscopy rooms from a location in Winston-Salem to a new ambulatory surgery center in Kernersville. The project, which would shift the rooms from the Piedmont Endoscopy Center, would cost more than $1.3 million, according to the certificate-of-need application. Kernersville Endoscopy said in its application that the project is not competitive and has asked for expedited review. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - November 22, 2017 Category: American Health Authors: Jessica Seaman Source Type: news
Mucosal healing: An objective measure of disease activity?
(Boston University School of Medicine) The absence of inflammatory and ulcerative lesions in all segments of the colon, also known as mucosal healing, should be the end goal in treating patients with ulcerative colitis according to an editorial in the journal Gastrointestinal Endoscopy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 21, 2017 Category: International Medicine & Public Health Source Type: news
Endoscopy Could Spare More Barrett's Patients From Surgery Endoscopy Could Spare More Barrett's Patients From Surgery
For patients with Barrett's esophagus, endoscopy, a recognized treatment for high-grade dysplasia, is just as effective for intramucosal carcinoma, new research shows.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 17, 2017 Category: Consumer Health News Tags: Gastroenterology News Source Type: news
Report from groundbreaking 'EndoVators Summit' offers guidance for obesity treatment
(American Society for Gastrointestinal Endoscopy) A recently published white paper from the American Society for Gastrointestinal Endoscopy and the Association for Bariatric Endoscopy breaks new ground in defining the role and value of the latest approaches for obesity management. The paper reports on the scope and impact of the obesity problem as well as the multiple factors and players involved in treating this chronic condition. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 9, 2017 Category: International Medicine & Public Health Source Type: news
7 medtech stories we missed this week: Nov. 3, 2017
[Image from unsplash.com]From Hologic’s new product launch to CapsoVision gettting CE Mark approval, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Hologic launches new MyoSure device Hologic announced in a Nov. 1 press release that it has launched its MyoSure Manual Device in the U.S. The device is designed to help doctors resect and remove intrauterine tissue easily in an office setting if used with the MyoSure hysteroscope. 2. IntraFuse wins FDA clearance for FlexThread fibula pin IntraFuse has received FDA 510(k) clearance for its FlexThread Fibula Pin System, ...
Source: Mass Device - November 3, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Endoscopic / Arthroscopic Oncology Orthopedics Pain Management Regulatory/Compliance Surgical Ultrasound Women's Health brhmedical CapsoVision Helomics Hologic Inc. IntraFuse MedTech Sensus Healthcare LLC Skyline Med Source Type: news
Ambu pays $261m for Invendo Medical
Ambu (CPH:AMBU-B) this week said it agreed to put $261 million on the table for Invendo Medical and its line of disposable endoscopy devices. Copenhagen-based Ambu said it paid $133.2 million (€115 million) up front for Invendo, with another $127.4 million (€110 million) in possible milestones. Those include a $81.1 million (€70 million) payment pegged to FDA clearances and $46.3 million (€40 million) in earnouts over four years. Some $11.6 million (€10 million) is expected to come due this fiscal year after Invendo wins 510(k) clearance from the FDA for the next iteration of its HD colon...
Source: Mass Device - October 27, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Hospital Care Mergers & Acquisitions Wall Street Beat Ambu Invendo Medical Source Type: news
Olympus Announces Continued Expansion of Its GI Endoscopic Device Line with ESD Innovations
SB Knives, Eleview and Guardian Driving Complete Solutions for Gastroenterologists CENTER VALLEY, Pa., Oct. 13, 2017 -- (Healthcare Sales & Marketing Network) -- Olympus, a global technology leader in designing and delivering innovative solutions for m... Devices, Gastroenterology, Product Launch Olympus Medical Systems, EndoTherapy, endoscopy, Submucosal Dissection (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 13, 2017 Category: Pharmaceuticals Source Type: news
New studies add to understanding of treatments for Barrett's esophagus
(American Society for Gastrointestinal Endoscopy) The October issue of GIE: Gastrointestinal Endoscopy features several new studies evaluating various treatments for Barrett's esophagus (BE). BE is a condition in which there are unusual changes to the cells lining the esophagus. It is believed to be most commonly due to inflammation from gastroesophageal reflux disease (GERD). Sometimes these changes may be considered precancerous. Endoscopic treatments for BE focus on removing or destroying the problematic tissue. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 6, 2017 Category: Cancer & Oncology Source Type: news
Olympus launches joint Sony-developed Orbeye 4K-3D video microscope
Olympus (TYO:7733) said today it launched its Orbeye 4K-3D video microscope developed by Sony Olympus Medical solutions, a joint venture between Olympus and Sony‘s (TYO:6758) Imaging Products & Solutions biz. The company said the Orbeye microscope is designed to provide high-resolution 3D imaging of the structure of tissue, blood vessels and other features to enable more accurate surgery. The system includes a 55-inch display to allow for simultaneous surgical team viewing. “The Orbeye exoscope represents the next generation of operative imaging- a true quantum shift. Its adoption is certain and w...
Source: Mass Device - October 5, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Imaging Olympus Sony Corp. Source Type: news
MM-24 Series Medical-Grade Monitors feature rear VESA mount holes.
MM-24 Series Medical-Grade Monitors come with 24 in. screen with a HD resolution of 1920 x 1080. Units are integrated with VGA, HDMI, DisplayPort and DVI video inputs and are available with internal or external Medical-Grade power supplies. Products offer viewing angle of 178 in. x 178 in. and are suitable for medical carts in ICU’s, and endoscopy and medical system applications. Monitors are offered with boom arms, table top bases, wall and ceiling mounts.This story is related to the following:Health, Medical,& Dental Supplies and EquipmentSearch for suppliers of:Patient Monitoring Equipment (Source: Industr...
Source: Industrial Newsroom - Health, Medical and Dental Supplies - October 3, 2017 Category: Medical Devices Source Type: news
The Human Experience: How Patients Inspire Innovation and Why Medtech Should Listen
Discussions centered on patient-centered, outward-looking technology with an emphasis on data and patient engagement. The medtech CEO, physician, and hospital executive all consider innovation differently, but they all have the patient as the muse. What Patient-Inspired Innovation Means Todd Dunn, innovation director for Intermountain Healthcare, said during a conference panel that his organization created a new initiative to put empathy at the forefront of innovation. He said Proctor & Gamble's "immersion research," where executives spend time in people's homes to understand what matters to them, inspired hi...
Source: MDDI - September 30, 2017 Category: Medical Devices Authors: Heather R. Johnson Tags: Medical Device Business Source Type: news
Boston Scientific launches third Connected Patient Challenge
Boston Scientific today announced the launch of its third annual Connected Patient Challenge, which it is holding in collaboration with Google and Medstro. The last competition was about big data, artificial intelligence and patient-engagement technologies. This time around, the competition is offering winners up to $50,000 in services to help them realize their big idea about how to use the Internet of Things to improve diagnosis, treatment, monitoring or patient care. The goal is to find IoT solutions in neuromodulation, cardiac rhythm management, cardiology, electrophysiology, peripheral interventions, oncolog...
Source: Mass Device - September 26, 2017 Category: Medical Devices Authors: Chris Newmarker Tags: Big Data Diagnostics Patient Monitoring Research & Development Boston Scientific Connected Patient Challenge google Google Inc. Medstro Source Type: news
More Post-endoscopy GI Bleeding With Warfarin Than Direct Oral Anticoagulants More Post-endoscopy GI Bleeding With Warfarin Than Direct Oral Anticoagulants
Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - September 21, 2017 Category: Surgery Tags: Gastroenterology News Source Type: news
Cook Medical parent company sells subsidiary for $950M
The parent company of Cook Medical, which operates an endoscopy division in Winston-Salem, has sold one of its subsidiary companies for $950 million. Cook Group announced Tuesday that it is selling Cook Pharmica, a privately held, biologics-focused contract development and manufacturing organization, to Somerset, N.J.-based Catalent for $750 million cash at closing and the remainder in four annual installments. The Winston-Salem facility, whic h focuses on medical device manufacturing, is wholly… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 20, 2017 Category: American Health Authors: Rebecca Troyer Source Type: news
Standards for Upper GI Endoscopy Released Standards for Upper GI Endoscopy Released
The BSG and AUGIS jointly released recommendations to improve the quality of upper gastrointestinal endoscopy and reduce the risk for missed early cancerous lesions.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 19, 2017 Category: Consumer Health News Tags: Gastroenterology News Source Type: news
Pentax Medical wins CE Mark for DEC duodenoscope
Hoya‘s Pentax Medical said today it won CE Mark approval in the European Union for its DEC duodenoscope featuring a disposable elevator cup. The Tokyo-based company said the new device features a combination of advanced cleaning capabilities and improved infection prevention controls to ensure a more reliable performance. The new device also features improved high definition video quality. The DEC’s single-use, sterile, distal end cap was designed to reduce the likelihood of carbapenem-resistant Enterobacteriaceae infections which have been linked to duodenoscope devices. “The new DEC Duodensocope is...
Source: Mass Device - September 19, 2017 Category: Medical Devices Authors: Fink Densford Tags: Imaging Regulatory/Compliance Hoya Corp. Pentax Medical Source Type: news